VacZine Analytics  
MarketVIEW: Biodefense vaccines

Published: September 2015

Since the 2001 terrorist attacks and continued threats at a global level against many Western governments, the concept of biodefense has become an important component of many national countermeasure strategies. To this end, a number of chemical, biologica1 , radiological, and nuclear (CBRN) terrorism agents were identified as part of a new US law passed in 2004 known as the Project Bioshield Act. This act allowed the US government to guarantee a market for CBRN countermeasures, which up until June 2014 obligated approximately $3.309 bn in funding.

Despite Project Bioshield and The Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (PAHPRA), which has effectively extended the Project BioShield procurement program to FY2018, the US HHS has obligated 90% to just three threats: anthrax, smallpox, and botulinum toxin. Project BioShield did not acquire any countermeasures against the other eight material CBRN threats, meaning that a significant amount of research and development is still required.

This MarketVIEW report covers in depth the background, legislation and current US capabilities with regard to biodefense vaccines with a focus on anthrax, smallpox and other biodefense vaccines. For anthrax and smallpox, detailed coverage is provided on disease epidemiology, past and current vaccines/associated recommendations/policy and corporate development of new generation vaccines for inclusion to the future US Strategic National Stockpile. The objective of this report is to give the reader a full background into the biodefense industry so that future dynamics/trends can be visualized for potential strategy development or market entry.

THIS PRODUCT IS A EXECUTIVE PRESENTATION

To order please contact your region account manager, buy "on-line" or order direct at: orders@vaczine-analytics.com

CAT No: CONTENTS: PURCHASE:
VAMV063 Click here>>
Choose option:
*Prices quotes are for 1 region license only. Regions are North America, or EU or ROW. For UK orders VAT will be added at 20%. Please review the TERMS and CONDITIONS of purchase.

Return to main list>> Questions about this report?






© 2015 VacZine Analytics. All rights reserved. Disclaimer | Privacy | Terms and conditions. hosted by chillydomains